title: [Treatment of hypertension in a clinical trial. Depot alpha 1 blocker simplifies dosing].
authors.affiliation: Klinische Forschung, Pfizer Deutschland, Postfach 4949, D-76032 Karlsruhe. norbert.sauerbrey-wullkopf@pfizer.com
authors.forename: N
authors.initials: N
authors.lastname: Sauerbrey-Wullkopf
authors.forename: F
authors.initials: F
authors.lastname: Leverkus
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000008:administration & dosage*; D000959:Antihypertensive Agents / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D003692:Delayed-Action Preparations; D004305:Dose-Response Relationship, Drug; D017292:Doxazosin / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*
chemical_list: D000317:Adrenergic alpha-Antagonists; D000959:Antihypertensive Agents; D003692:Delayed-Action Preparations; D017292:Doxazosin